Vera Therapeutics Price To Sales Ratio Over Time

Stocks . USA . 
Stock . Vera Therapeutics
VERA Stock  USD 48.83  1.37  2.89%   
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Vera Therapeutics Performance and Vera Therapeutics Correlation.
For information on how to trade Vera Stock refer to our How to Trade Vera Stock guide.
  
As of November 29, 2024, Price To Sales Ratio is expected to decline to 282.21.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vera Therapeutics. If investors know Vera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vera Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.61)
Return On Assets
(0.33)
Return On Equity
(0.65)
The market value of Vera Therapeutics is measured differently than its book value, which is the value of Vera that is recorded on the company's balance sheet. Investors also form their own opinion of Vera Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Vera Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vera Therapeutics' market value can be influenced by many factors that don't directly affect Vera Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Vera Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Vera Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vera Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Specify up to 10 symbols:
Apply

Cross Equities Price To Sales Ratio Analysis

Compare Vera Therapeutics and related stocks such as Third Harmonic Bio, Cullinan Oncology LLC, and Edgewise Therapeutics Price To Sales Ratio Over Time
Select Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Price Book Value RatioPrice Earnings To Growth Ratio
Days Of Payables OutstandingDividend Payout Ratio
Price To Operating Cash Flows RatioPrice To Free Cash Flows Ratio
Pretax Profit MarginEbt Per Ebit
Operating Profit MarginEffective Tax Rate
Company Equity MultiplierLong Term Debt To Capitalization
Total Debt To CapitalizationReturn On Capital Employed
Debt Equity RatioEbit Per Revenue
Quick RatioDividend Paid And Capex Coverage Ratio
Net Income Per E B TCash Ratio
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity
201020112012201320142015201620172018201920202021202220232024
THRD0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
CGEM36.078136.078136.078136.078136.078136.078136.078136.078136.078136.078136.078136.078136.078132.4728.86
EWTX0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
RLYB0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
GLUE0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
TVTX10.868210.868210.868210.868210.86826.48085.24265.27235.56973.4296.53338.16386.32424.5976.88
CYTK2.700216.99199.48595.78466.093514.1114.560930.119910.918222.73624.016849.759543.51271.1 K1.1 K
VTYX0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
COGT20.393520.393520.393520.393520.393520.39359.58229.201311.25340.975415.810315.810315.810318.1812.32
CNTB0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
TYRA0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
RAPT94.536494.536494.536494.536494.536494.536494.536494.536494.536494.536494.5364264422380208
XLO0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
MLYS0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
ANEB0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
ADAG6836836836836836836836836832.8 K2.2 K31.7386.17514.66644.43
ACRV0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
ANAB18118118118115.192413.69418.503319931554.96367.826615.088784.848233.613831.93
TARS8.10968.10968.10968.10968.10968.10968.10968.10968.10968.10968.10968.109613.980734.103935.81
ALDX0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
ETON1331331331331331331331331331334.4 K4.95323.33683.54993.37

Vera Therapeutics and related stocks such as Third Harmonic Bio, Cullinan Oncology LLC, and Edgewise Therapeutics Price To Sales Ratio description

Price to Sales Ratio is figured by comparing Vera Therapeutics stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Vera Therapeutics sales, a figure that is much harder to manipulate than other Vera Therapeutics multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

My Equities

My Current Equities and Potential Positions

View AllNext
Vera Therapeutics
VERA
ClassificationPharmaceutical Products
LocationCalifornia; U.S.A
ExchangeNASDAQ Exchange
USD 48.83
When determining whether Vera Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Vera Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vera Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Vera Therapeutics Stock:
How To Invest In Vera
Details
Is Vera Stock a good investment?
Details
What is Vera Therapeutics' Net Worth?
Details
Largest Biotechnology Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out Vera Therapeutics Performance and Vera Therapeutics Correlation.
For information on how to trade Vera Stock refer to our How to Trade Vera Stock guide.
You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Vera Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Overlap Analysis
View
Forecast Models
View
Price Shifting
View
Volatility Indicators
View
Value Movement
View
A focus of Vera Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Vera Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY